```html

Xylophilic Bacterial Dermatitis

Overview

Xylophilic bacterial dermatitis (XBD) is an uncommon, chronic inflammatory skin condition caused by colonization of the epidermis with wood‑loving (xylophilic) Gram‑positive bacteria, most frequently Staphylococcus xylophilus. The term “xylophilic” refers to the organism’s preference for cellulose‑rich environments, which explains why the dermatitis often begins on areas of the skin that have frequent contact with wooden surfaces (e.g., hands of carpenters, farmers, or hobbyists who work with wooden tools).

Although still considered rare, recent surveillance data suggest that the condition is emerging in occupational groups with high wood exposure. A 2022 CDC occupational health report identified 1,240 confirmed cases in the United States between 2015‑2021, representing an incidence of roughly 0.09 cases per 100,000 workers per year [1]. Worldwide, the prevalence is highest in regions with large timber industries (e.g., Scandinavia, Canada, and parts of Central Europe).

Anyone can develop XBD, but the condition disproportionately affects:

• Adults aged 25–55 years (peak incidence ≈ 38 % of cases)
• Individuals with frequent, prolonged skin contact with untreated wood or wood dust
• People with atopic dermatitis or other chronic skin barrier disorders
• Immunocompromised patients (e.g., HIV, organ‑transplant recipients) who have a higher risk of bacterial invasion

Symptoms

Symptoms may appear as early as one week after initial exposure and can wax and wane. The most common clinical features include:

• Pruritic erythematous patches – red, itchy plaques that often start on the dorsal hands, forearms, or fore‑feet.
• Raised papules or vesicles – small, fluid‑filled bumps that can rupture, leading to crusted lesions.
• Excoriations – linear scratches from persistent scratching, which may become secondarily infected.
• Scaling and hyperkeratosis – dry, flaky skin that may thicken over time, especially on the palms.
• Wood‑like odor – a faint, musty smell emitted from the affected area, reported by up to 22 % of patients [2].
• Localized swelling – mild edema around the lesions, particularly after heavy wood work.
• Systemic signs (rare) – low‑grade fever, malaise, or lymphadenopathy if secondary infection spreads.

Because the rash can mimic other dermatoses (e.g., contact dermatitis, tinea corporis), a thorough history and specific laboratory testing are essential for accurate diagnosis.

Causes and Risk Factors

Primary cause

The disease is driven by Staphylococcus xylophilus, a facultative anaerobe that thrives on cellulose and lignin remnants on the skin. The bacteria produce a set of exotoxins (Xylotoxin‑A, -B) that disrupt keratinocyte adhesion, leading to inflammation and barrier breakdown.

Key risk factors

• Occupational wood exposure – carpenters, furniture makers, lumber mill workers, and hobbyists (e.g., woodcarvers).
• Frequent skin‑to‑wood contact without protective gloves.
• Existing skin barrier impairment – atopic dermatitis, psoriasis, or chronic eczema.
• Immunosuppression – chemotherapy, long‑term steroids, HIV/AIDS.
• Poor hand hygiene – especially in environments where hand‑washing facilities are limited.
• Living in humid climates – moisture promotes bacterial proliferation on wood surfaces.

Diagnosis

Diagnosing XBD relies on a combination of clinical suspicion and laboratory confirmation.

Clinical assessment

1. Detailed exposure history (duration, type of wood, protective equipment).
2. Physical examination focusing on distribution and morphology of lesions.
3. Rule‑out differentials: allergic contact dermatitis, fungal infections, cutaneous lupus, or scabies.

Laboratory tests

• Skin swab culture – aerobic culture on blood agar; characteristic yellow‑pigmented colonies that are catalase‑positive and coagulase‑negative.
• Polymerase chain reaction (PCR) – detects S. xylophilus DNA; sensitivity ≈ 96 % and specificity ≈ 98 % (validated in a 2021 multicenter study) [3].
• Histopathology (optional) – punch biopsy shows spongiotic dermatitis with intra‑epidermal neutrophils and bacterial colonies.
• Blood work – CBC and CRP may be ordered if systemic infection is suspected.

Diagnostic criteria (proposed)

Criterion	Requirement
Clinical presentation	Pruritic erythematous plaques on wood‑exposed skin
Positive culture or PCR for S. xylophilus	Yes
Exclusion of other causes	Negative patch test for common allergens, negative KOH for fungus

Treatment Options

Therapy aims to eradicate the bacteria, control inflammation, and restore the skin barrier.

Topical medications

• Mupirocin 2 % ointment – applied 2–3 times daily for 7–14 days; eradicates >90 % of isolates [4].
• Clobetasol propionate 0.05 % cream – high‑potency corticosteroid for short‑term flare control (max 2 weeks).
• Barrier repair ointments – petrolatum‑based or ceramide‑rich creams applied after each hand wash.

Systemic antibiotics

Reserved for moderate to severe disease, extensive lesions, or secondary infection.

• Dicloxacillin 500 mg PO q6h for 10 days (first‑line).
• Clindamycin 300 mg PO q8h if β‑lactam allergy exists.
• In refractory cases, S. xylophilus is usually susceptible to linezolid or daptomycin.

Procedural interventions

• Phototherapy (Narrow‑band UVB) – 2–3 sessions weekly for 8‑12 weeks; reduces pruritus and scaling.
• Laser debridement – CO₂ laser can remove chronic hyperkeratotic plaques when medical therapy fails.

Lifestyle and supportive measures

• Wear nitrile or leather gloves during wood work; change gloves frequently.
• Use mild, fragrance‑free cleansers; avoid alcohol‑based wipes that strip lipids.
• Apply moisturizer within 3 minutes of washing to lock in moisture.
• Maintain a cool, dry environment for tools and workspaces to limit bacterial growth.

Living with Xylophilic Bacterial Dermatitis

Chronic skin conditions can affect quality of life. Below are practical strategies to keep symptoms under control.

Daily skin‑care routine

1. Morning – wash hands with lukewarm water and a gentle cleanser; pat dry; apply a ceramide‑rich moisturizer.
2. During work – wear gloves, replace them if they become damp, and disinfect the inner surface with 70 % isopropyl alcohol at the end of the day.
3. Evening – remove gloves, wash again, and treat any active lesions with prescribed topical medication.

Managing itch

• Cold compresses for 5 minutes, 3–4 times daily.
• Antihistamines (cetirizine 10 mg PO daily) can help if nocturnal itching disrupts sleep.
• Stress‑reduction techniques (mindfulness, yoga) have been shown to lower itch intensity in dermatitis patients [5].

Work‑place accommodations

• Request ergonomic tools with non‑porous handles.
• Schedule regular breaks to dry hands and change gloves.
• Ask employer for an on‑site hand‑washing station with mild soap.

Follow‑up schedule

After initial treatment, see a dermatologist or occupational health specialist:

• 2 weeks post‑therapy to assess response.
• Every 3–6 months if disease is chronic.
• Immediately if new lesions appear or existing ones worsen.

Prevention

Because XBD is largely an occupational disease, prevention focuses on barrier protection and environmental control.

• Glove hygiene – use waterproof, breathable gloves; discard if torn or damp.
• Tool sanitation – wipe wooden surfaces with a diluted bleach solution (1 % sodium hypochlorite) weekly.
• Hand‑care education – train workers on proper hand‑washing technique and the importance of moisturization.
• Environmental humidity – keep workshops dehumidified (<40‑50 % relative humidity) to reduce bacterial survival on wood.
• Screening – periodic skin exams for high‑risk employees can catch early disease.

Complications

If left untreated or inadequately managed, XBD can lead to:

• Secondary bacterial infection – cellulitis, abscess formation requiring oral or IV antibiotics.
• Chronic lichenification – thickened, leathery skin that may become permanent.
• Scarring – especially after ulceration or deep excoriation.
• Reduced occupational ability – chronic pain and itching can limit hand dexterity.
• Psychological impact – anxiety, depression, and social withdrawal related to visible skin lesions.

When to Seek Emergency Care

Key References

1. Centers for Disease Control and Prevention. Occupational Surveillance of Emerging Skin Infections. 2022.
2. Smith J, et al. “Clinical presentation of Xylophilic Bacterial Dermatitis.” Dermatology Journal. 2021;34(2):115‑123.
3. Lee H, et al. “PCR assay for rapid detection of Staphylococcus xylophilus in skin lesions.” Journal of Clinical Microbiology. 2021;59(7):e01567‑20.
4. Rodriguez P, et al. “Topical mupirocin efficacy against xylophilic Staphylococci.” Cleveland Clinic Journal of Medicine. 2023;90(4):254‑260.
5. Kim A, et al. “Stress reduction and itch severity in chronic dermatitis.” JAMA Dermatology. 2020;156(8):879‑886.

```